Neutropenic Colitis as a Complication of High-dose Chemotherapy for Refractory Testicular Cancer

Japanese Journal of Clinical Oncology

Volumn 28, Issue 9, 1998, Pages 571-573

  Kawai, Koji ^a   Imada, Seiki ^a   Iida, Katsuyuki ^a   Tsukamoto, Sadamu ^a   Miyanaga, Naoto ^a   Akaza, Hideyuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

High dose chemotherapy; Neutropenic colitis; Testicular cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CEC PROTOCOL; CYCLOPHOSPHAMIDE; ETOPOSIDE;

ADULT; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; CHORIOCARCINOMA; COLITIS; DRUG ADMINISTRATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; NEUTROPENIA; SEMINOMA; TESTIS TUMOR;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHORIOCARCINOMA; COLITIS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; NEUTROPENIA; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 0032160324     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/28.9.571     Document Type: Article

References (12)

1. Mother RJ, Bosl GJ. High-dose chemotherapy of resistant germ cell tumors: recent advances and future directions. J Natl Cancer Inst 1992;84:1703-9.
2. Ettinghausen SE. Neutropenic colitis. Surg Clin North Am 1993;73:1003-16.
3. Motzer RJ, Mazumdar M, Bosl GJ, Bajorin DF, Amsterdam, Vlamis V. High-dose carboplatin, etoposide and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity. J Clin Oncol 1996;14:1098-1105
4. Aoki H, Kodama M, Tani T, Hanasawa K. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber. Am J Surg 1994;167:412-7.
5. Starnes HF, Moore FD, Mentzer S, Osteen RT, Steele GD, Wilson RE. Abdominal pain in neutropenic cancer patients. Cancer 1986;57:616-21.
6. Mulholland MW, Delaney JP. Neutropenic colitis and aplastic anemia Ann Surg 1983;197:84-90.
7. Frick MP, Maile CW, Crass JR, Goldberg ME,Delaney JP. Computed tomography of neutropenic colitis. AJR 1984;143:763-5
8. Vohra R, Prescott RJ, Banerjee SS, Wilkinson PM, Schofield PF Management of neutropenic colitis, Surg Oncol 1982;1:11-5.
9. Mehta J, Nagler A, Or R, Kapelushnik J, Slavin S. Neutropenic enterocolitis and intestinal perforation associated with carboplatin-containing conditioning regimen for autologous bone marrow transplantation. Acta Oncol 1992;31:591.
10. Kronawitter U, Kemeny NE, Blumgart L. Neutropenic enterocolitis in a patient with colorectal carcinoma. Cancer 1997;80:656-60.
11. Motzer RJ, Mazumdar M, Gulati SC. Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. J Natl Cancer Inst 1993;85:1828-35
12. Siegert W, Beyer J, Strohscheer I, Baurmann H, Oettle H, Zingsem J, et al. High-dose treatment with carboplatin, etoposide and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer a phase I/II study. J Clin Oncol 1994;12:1223-31.